Last $10.05 USD
Change Today -0.05 / -0.50%
Volume 29.9K
CUTR On Other Exchanges
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

cutera inc (CUTR) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/4/14 - $11.82
52 Week Low
05/9/14 - $8.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CUTERA INC (CUTR)

cutera inc (CUTR) Related Bloomberg News

View More Bloomberg News

cutera inc (CUTR) Related Businessweek News

No Related Businessweek News Found

cutera inc (CUTR) Details

Cutera, Inc., a medical device company, is engaged in the design, development, manufacture, marketing, and service of laser and other energy based aesthetics systems for practitioners worldwide. The company offers products based on platforms/systems, such as Xeo, a multi-application platform on which customers purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity; and GenesisPlus, which is a laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis or toenail fungus. Its platforms also comprise ExcelV, a vascular platform that is primarily designed for the market of dermatologists and plastic surgeons; and truSculpt, which is a radio frequency platform designed for the non-invasive body contouring market. The company’s products include CoolGlide, Solera, and VariLite, as well as third-party sourced system myQ for the Japanese market. In addition, it provides upgrade services for customers; and post-warranty services through extended service contracts and direct billing. Further, the company distributes dermal filler products and prescription-based topical skin health systems to physicians in the Japanese market. It markets and sells its products primarily through direct sales forces, and distribution relationships and networks, as well as sells Titan hand piece refills and marketing brochures through Internet. The company’s customers also include gynecologists, primary care physicians, family practitioners, physicians offering aesthetic treatments in non-medical offices, podiatrists, and other qualified practitioners. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

238 Employees
Last Reported Date: 03/18/14
Founded in 1998

cutera inc (CUTR) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $523.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $329.2K
Compensation as of Fiscal Year 2013.

cutera inc (CUTR) Key Developments

Cutera Receives FDA 510(k) Clearance for enlighten

Cutera, Inc. announced that its enlighten laser platform received U.S. Food and Drug Administration 510(k) clearance for the treatment of benign pigmented lesions. enlighten is the first and only dual wavelength (532 nm/1064 nm) and dual pulse duration picosecond laser system cleared for sale in the United States.

Cutera, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2014; Provides Revenue Guidance for the Third Quarter and Full Year of 2014

Cutera, Inc. reported unaudited consolidated earnings results for the second quarter ended June 30, 2014. For the quarter, the company reported net revenue of $17.724 million compared to $19.560 million a year ago. Loss from operations was $2.835 million compared to $0.623 million a year ago. Loss before income taxes was $2.697 million compared to $0.548 million a year ago. Net loss was $2.741 million or $0.19 per basic and diluted share compared to $0.638 million or $0.04 per basic and diluted share a year ago. This loss is largely attributed to ramp-up costs related to the expanded sales force and other investments in North American commercial operations. Net cash used in operating activities was $2.520 million compared to net cash provided by operating activities of $1.850 million a year ago. Acquisition of property, equipment and software was $0.044 million compared to $0.132 million a year ago. The company expects year-over-year revenue growth commencing in the third quarter of 2014 and to improve profitability due to the leverage in business model. The company expects that sales and marketing spending will be relatively high as a percentage of revenue in 2014, but expect it to decline in 2015 as the company drive revenue growth from these investments.

Cutera Appoints Miguel Pardos as Executive Vice President of International

Cutera, Inc. announced the expansion of its sales and marketing organization to bring greater focus on its international business. Mr. Miguel Pardos recently joined Cutera as Executive Vice President of International. He brings over twenty years of experience in building and leading international sales and marketing organizations in global medical device companies. In his prior roles, he has delivered significant revenue growth through growing direct operations as well as building strong distribution partnerships. For the past five years, Miguel served as Vice President of Asia Pacific for an aesthetic capital equipment company and prior to that spent fifteen years at GE Healthcare where he held a variety of leadership roles in Spain, Germany, Australia and Singapore.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CUTR:US $10.05 USD -0.05

CUTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biolase Inc $2.35 USD -0.14
Iridex Corp $6.93 USD -0.075
Lutronic Corp 19,150 KRW -300.00
STAAR Surgical Co $10.03 USD -0.60
SurModics Inc $18.84 USD +0.68
View Industry Companies

Industry Analysis


Industry Average

Valuation CUTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CUTERA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at